Status:
RECRUITING
SCOOT: Sample Collection for DART
Lead Sponsor:
University of Oxford
Collaborating Sponsors:
Innovate UK
Optellum
Conditions:
Lung Cancer
Eligibility:
All Genders
55-75 years
Brief Summary
The study will use a blood sample collected from participants to: * Develop new ways of finding and diagnosing lung health problems, such as lung cancer. * Develop tools which make it easier to scree...
Detailed Description
The results from this study will be linked with the data from the DART study (also collecting data through the Lung Health Check programme) to develop new ways of using computer technology (artificial...
Eligibility Criteria
Inclusion
- Patient suitability will be assessed against the below criteria by the clinical teams managing the patients.
- Patients with a pulmonary nodule or nodule(s) detected on a CT scan performed as part of Lung Cancer Screening from the Lung Health Check centres, that require further investigation with a PET-CT scan, and / or biopsy, and / or resection
- Willing and able to give informed consent
Exclusion
- None -
Key Trial Info
Start Date :
August 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT05368298
Start Date
August 11 2022
End Date
December 31 2025
Last Update
November 18 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Lung Health Check: Oxford - Churchill Hospital, OUH
Oxford, Oxfordshire, United Kingdom
2
Lung Health Check Centre: Royal Sussex
Brighton, United Kingdom
3
Lung Health Check Centre: North Bristol
Bristol, United Kingdom
4
Lung Health Check Centre: Gateshead
Gateshead, United Kingdom